The latest trial results found Enhertu slashed the chances of terminal breast cancer growing or spreading by 38 per cent compared to standard chemotherapy.The latest trial results found Enhertu slashed the chances of terminal breast cancer growing or spreading by 38 per cent compared to standard chemotherapy.Read MoreHealth News | Mail Online
![](https://ourbodyhealth.info/wp-content/uploads/2024/06/85657559-0-image-m-17_1717428342765-hcQT2w.jpeg)